Commonwealth Equity Services’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $519K | Sell |
55,055
-695
| -1% | -$6.23K | ﹤0.01% | 3287 |
|
|
2026
Q1 | $454K | Buy |
55,750
+5,652
| +11% | +$51.2K | ﹤0.01% | 3294 |
|
|
2025
Q4 | $337K | Sell |
50,098
-174
| -0.3% | -$1.31K | ﹤0.01% | 3554 |
|
|
2025
Q3 | $436K | Sell |
50,272
-5,791
| -10% | -$45.1K | ﹤0.01% | 3296 |
|
|
2025
Q2 | $353K | Buy |
56,063
+5,543
| +11% | +$36.7K | ﹤0.01% | 3449 |
|
|
2025
Q1 | $324K | Buy |
50,520
+7,486
| +17% | +$61.9K | ﹤0.01% | 3425 |
|
|
2024
Q4 | $346K | Buy |
43,034
+3,236
| +8% | +$31.2K | ﹤0.01% | 3290 |
|
|
2024
Q3 | $503K | Sell |
39,798
-3,639
| -8% | -$47K | ﹤0.01% | 2887 |
|
|
2024
Q2 | $550K | Sell |
43,437
-21,182
| -33% | -$213K | ﹤0.01% | 2757 |
|
|
2024
Q1 | $309K | Buy |
64,619
+46,311
| +253% | +$215K | ﹤0.01% | 3248 |
|
|
2023
Q4 | $88K | Buy |
18,308
+1,001
| +6% | +$6.13K | ﹤0.01% | 3690 |
|
|
2023
Q3 | $125K | Buy |
17,307
+2,201
| +15% | +$17.6K | ﹤0.01% | 3524 |
|
|
2023
Q2 | $112K | Buy |
15,106
+1,809
| +14% | +$14.2K | ﹤0.01% | 3554 |
|
|
2023
Q1 | $92K | Sell |
13,297
-15
| -0.1% | -$138 | ﹤0.01% | 3506 |
|
|
2022
Q4 | $136K | Buy |
13,312
+1,804
| +16% | +$31.8K | ﹤0.01% | 3350 |
|
|
2022
Q3 | $209K | Sell |
11,508
-1,703
| -13% | -$73.8K | ﹤0.01% | 3129 |
|
|
2022
Q2 | $679K | Buy |
13,211
+2,050
| +18% | +$106K | ﹤0.01% | 2195 |
|
|
2022
Q1 | $822K | Sell |
11,161
-1,603
| -13% | -$143K | ﹤0.01% | 2136 |
|
|
2021
Q4 | $1.83M | Buy |
12,764
+171
| +1% | +$29.4K | ﹤0.01% | 1558 |
|
|
2021
Q3 | $2.61M | Buy |
12,593
+2,746
| +28% | +$605K | 0.01% | 1274 |
|
|
2021
Q2 | $2.09M | Buy |
9,847
+213
| +2% | +$39K | 0.01% | 1391 |
|
|
2021
Q1 | $1.75M | Sell |
9,634
-3,117
| -24% | -$621K | ﹤0.01% | 1420 |
|
|
2020
Q4 | $1.42M | Sell |
12,751
-2,703
| -17% | -$287K | ﹤0.01% | 1426 |
|
|
2020
Q3 | $1.67M | Buy |
15,454
+5,577
| +56% | +$679K | 0.01% | 1194 |
|
|
2020
Q2 | $823K | Sell |
9,877
-4,710
| -32% | -$180K | ﹤0.01% | 1546 |
|
|
2020
Q1 | $198K | Buy |
14,587
+1,236
| +9% | +$10.5K | ﹤0.01% | 2399 |
|
|
2019
Q4 | $53K | Buy |
+13,351
| New | +$57.9K | ﹤0.01% | 2795 |
|
|
2019
Q2 | – | Sell |
-5,928
| Closed | -$65K | – | 2802 |
|
|
2019
Q1 | $65K | Sell |
5,928
-10,592
| -64% | -$334K | ﹤0.01% | 2646 |
|
|
2018
Q4 | $607K | Buy |
16,520
+675
| +4% | +$26.2K | ﹤0.01% | 1509 |
|
|
2018
Q3 | $595K | Sell |
15,845
-933
| -6% | -$26.3K | ﹤0.01% | 1671 |
|
|
2018
Q2 | $450K | Sell |
16,778
-181
| -1% | -$6.12K | ﹤0.01% | 1829 |
|
|
2018
Q1 | $712K | Buy |
16,959
+2,315
| +16% | +$93K | ﹤0.01% | 1460 |
|
|
2017
Q4 | $363K | Sell |
14,644
-283
| -2% | -$6.9K | ﹤0.01% | 1915 |
|
|
2017
Q3 | $340K | Sell |
14,927
-32
| -0.2% | -$716 | ﹤0.01% | 1877 |
|
|
2017
Q2 | $344K | Buy |
14,959
+1,560
| +12% | +$30.6K | ﹤0.01% | 1824 |
|
|
2017
Q1 | $343K | Buy |
13,399
+122
| +0.9% | +$3.35K | ﹤0.01% | 1764 |
|
|
2016
Q4 | $335K | Buy |
13,277
+1,125
| +9% | +$32.8K | ﹤0.01% | 1702 |
|
|
2016
Q3 | $506K | Buy |
12,152
+1,574
| +15% | +$203K | ﹤0.01% | 1374 |
|
|
2016
Q2 | $1.54M | Buy |
10,578
+2,259
| +27% | +$259K | 0.01% | 768 |
|
|
2016
Q1 | $858K | Buy |
8,319
+1,071
| +15% | +$115K | 0.01% | 1024 |
|
|
2015
Q4 | $1.22M | Buy |
7,248
+397
| +6% | +$61.1K | 0.01% | 832 |
|
|
2015
Q3 | $969K | Buy |
6,851
+640
| +10% | +$144K | 0.01% | 911 |
|
|
2015
Q2 | $1.38M | Sell |
6,211
-60
| -1% | -$10.5K | 0.01% | 784 |
|
|
2015
Q1 | $1.04M | Buy |
6,271
+335
| +6% | +$54.4K | 0.01% | 932 |
|
|
2014
Q4 | $704K | Buy |
5,936
+765
| +15% | +$80K | 0.01% | 1080 |
|
|
2014
Q3 | $431K | Buy |
5,171
+750
| +17% | +$67.8K | 0.01% | 1339 |
|
|
2014
Q2 | $409K | Buy |
4,421
+1,000
| +29% | +$87.9K | 0.01% | 1361 |
|
|
2014
Q1 | $310K | Buy |
3,421
+49
| +1% | +$5.47K | ﹤0.01% | 1441 |
|
|
2013
Q4 | $345K | Buy |
3,372
+2,250
| +201% | +$159K | 0.01% | 1352 |
|
|
2013
Q3 | $71K | Buy |
+1,122
| New | +$63.2K | ﹤0.01% | 1784 |
|
Other funds holding NVAX
SCM
S
Commonwealth Equity Services's NVAX Position: Q2 2026 in Review
Commonwealth Equity Services reduced its Novavax (NVAX) stake by 1.2% in Q2 2026, selling an estimated $6.23K and leaving 55,055 shares worth $519K. The position accounts for ﹤0.01% of the portfolio, ranked #3287.
Commonwealth Equity Services first reported a position in NVAX in Q3 2013 and has held it in 50 quarters since. The position peaked at $2.61M in Q3 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Commonwealth Equity Services held 55,055 shares of Novavax worth $519K as of Q2 2026.
- Commonwealth Equity Services sold 695 Novavax shares in Q2 2026, an estimated $6.23K.
- Novavax made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3287 holding.
- Commonwealth Equity Services first reported a position in Novavax in Q3 2013 and has held it in 50 quarters since.
- Commonwealth Equity Services's Novavax position peaked at $2.61M in Q3 2021.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.